e-learning
resources
Berlin 2008
Tuesday, 07.10.2008
Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
IFNγ induces steroid unresponsiveness in smokers alveolar macrophages
T. Southworth, H. Atcha, D. Singh (Manchester, United Kingdom)
Source:
Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Session:
Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology
Session type:
Thematic Poster Session
Number:
3713
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Southworth, H. Atcha, D. Singh (Manchester, United Kingdom). IFNγ induces steroid unresponsiveness in smokers alveolar macrophages. Eur Respir J 2008; 32: Suppl. 52, 3713
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Glucocorticoid sensitivity of LPS stimulated COPD alveolar macrophages
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
Induction of pro-inflammatory mediator release by cigarette smoke condensate: differential effects on alveolar epithelial cells and macrophages
Source: Eur Respir J 2003; 22: Suppl. 45, 81s
Year: 2003
Production of macrophage-derived chemokine by alveolar macrophages from cigarette smokers
Source: Eur Respir J 2003; 22: Suppl. 45, 454s
Year: 2003
No evidence of corticosteroid resistance in COPD alveolar macrophages
Source: Annual Congress 2009 - Translational research/biomarkers
Year: 2009
Glucocorticoids induce a shift in chemokine profile in LPS-stimulated human alveolar macrophages
Source: International Congress 2018 – Identification of therapeutic targets for asthma
Year: 2018
Azithromycin increases phagocytosis of apoptotic airway epithelial cells by alveolar macrophages
in vitro
Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research
Year: 2005
Azithromycin increases phagocytosis of apoptotic bronchial epithelial cells by alveolar macrophages
Source: Eur Respir J 2006; 28: 486-495
Year: 2006
Increased SDF-1alpha production from alveolar macrophages in sarcoidosis in vitro
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008
Resident alveolar macrophages mediate early alveolar epithelial death signaling and dysfunction
Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Year: 2012
A spatially restricted fibrotic niche in pulmonary fibrosis is sustained by M-CSF/M-CSFR signalling in monocyte-derived alveolar macrophages
Source: Eur Respir J, 55 (1) 1900646; 10.1183/13993003.00646-2019
Year: 2020
Preferential activation of alveolar macrophages versus epithelial cells during initiation of ventilator-induced lung injury in mice
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Interferon-g or azathioprine plus corticosteroids do not alter the expression of apoptotic markers in alveolar macrophages of patients with IPF
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011
Fluticasone increases in vitro efferocytosis by human alveolar macrophages
Source: Annual Congress 2010 - Asthma: clinical aspects and treatment
Year: 2010
Differential regulation of inflammatory pathways in alveolar macrophages from COPD patients and smoking controls
Source: Annual Congress 2007 - Novel mediators of cellular pathology
Year: 2007
IL-17A induces glucocorticoid insensitivity in airway epithelial cells
Source: Annual Congress 2011 - Epithelial cells: role in health and disease
Year: 2011
Cigarette smoke can increase the neutrophil recruitment in the airways of COPD patients by increasing PGE2 release in alveolar macrophages (AM)
Source: Eur Respir J 2003; 22: Suppl. 45, 85s
Year: 2003
Inhibition of cytokine release from alveolar macrophages in sarcoidosis by pentoxifylline: comparison with dexamethasone
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001
Effect of cigarette smoke extract and Th17 cytokine on production of inflammatory cytokines and chemokines in human airway smooth muscle cells
Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science
Year: 2021
Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages (AM) in COPD
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Overexpression of CBP augments cigarette smoke-induced pro-inflammatory cytokine release in macrophages
Source: Eur Respir J 2005; 26: Suppl. 49, 105s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept